Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis. 1999

E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
Department of Gastroenterology and Hepatology, and Endoscopic Medicine, Kyoto University Hospital, Japan.

Therapy with oral 5-aminosalicylic acid (5-ASA) for ulcerative colitis has been reported to be effective and safe. We describe a case of biochemically proven mild acute pancreatitis occurring after 9 d of oral 5-ASA therapy for ulcerative colitis. A hypersensitivity mechanism seemed to be involved in the development of pancreatitis probably owing to erratic systemic absorption of the drug. We suggest clinical and biochemical monitoring for early diagnosis of pancreatitis in patients with ulcerative colitis receiving 5-ASA administration. This is the first report of acute pancreatitis developed by oral 5-ASA therapy for the treatment of ulcerative colitis in the literature of Japan.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D019804 Mesalamine An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) 5-Aminosalicylate,Mesalazine,5-Aminosalicylic Acid,Asacol,Asacolon,Ascolitin,Canasa,Claversal,Fivasa,Lixacol,Mesalamine Hydrochloride,Mesalamine Monosodium Salt,Mesasal,Novo-5 ASA,Pentasa,Rowasa,Salofalk,m-Aminosalicylic Acid,meta-Aminosalicylic Acid,5 Aminosalicylate,5 Aminosalicylic Acid,Hydrochloride, Mesalamine,Monosodium Salt, Mesalamine,Novo 5 ASA,m Aminosalicylic Acid,meta Aminosalicylic Acid

Related Publications

E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
November 1993, Journal of pediatric gastroenterology and nutrition,
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
June 2014, La Tunisie medicale,
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
January 2000, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
December 2007, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi,
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
April 1994, The Italian journal of gastroenterology,
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
December 1993, Hospital practice (Office ed.),
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
May 2024, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi,
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
June 2008, Inflammatory bowel diseases,
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
January 2022, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi,
E Adachi, and K Okazaki, and Y Matsushima, and H Seno, and K Uchida, and H Nakase, and C Kawanami, and T Nakamura, and T Chiba
September 1995, Ugeskrift for laeger,
Copied contents to your clipboard!